
New liquid biopsy can detect eight common cancers
Blood test could ‘change the way we screen for cancer’, though more research is needed to ensure its efficacy in a real-world screening context

Cancer immunotherapy: predicting outcomes
Today's monoclonal antibody treatments benefit some patients but can be harmful to others; the search for reliable predictive biomarkers is on

Genome editing: Talking to patients
With genome editing hitting the headlines, patients may have questions about its applications. Here’s our concise guide for health professionals

Genomics in 2018: 3 key predictions
We asked three wise men and women to tell us what they think 2018 will bring for genomics in healthcare

What is NIPT?
Non-invasive prenatal testing will be rolled out in the NHS next year. But how does it work? And what are the benefits?

New precision medicine approaches to breast cancer
Patients in London and Manchester the first to benefit from methods to better predict, prevent and treat breast cancer, with aims to roll out nationally

Delivering the genomic dream
Ahead of her appearance at Expo 2017, Chief Scientific Officer Sue Hill outlines the exciting work she is leading on genomics across the NHS

Gene therapy hope for sickle cell anaemia patients
A teenager with severe sickle cell anaemia has been successfully treated with a pioneering gene therapy approach

Fighting adverse drug reactions
When it comes to therapeutic treatments, one size doesn’t fit all. Could genomic tests be the key to minimising the harmful side effects of drugs?

How genome editing could enter mainstream medicine
Forget designer babies and novelty pets. The potential for genome editing to improve the health of the general population is already emerging

Genomics in government policy
How do we bring exciting research, exceptional medicine and public opinion to routine clinical practice?

Point-of-care testing in genomics
Rapid advances in technology are revolutionising healthcare. How viable is portable DNA testing?